(Reuters) - Pfizer Inc <PFE.N> is exploring sale of a group of treatments in cardiology, urology and primary care, Bloomberg reported on Thursday, citing people familiar with the matter.
The drugs could fetch more than $2 billion, Bloomberg reported. (http://bloom.bg/2kWj1q1)
Pfizer is working with financial adviser JPMorgan Chase & Co for the potential portfolio sale and the process is at a preliminary stage, Bloomberg said.
- Celebrity deaths 2018: All the stars we lost too soon 46 Pictures
- Photos: Starbucks Reserve Roastery NYC reconnects you with your coffee 48 Pictures
Pfizer could not be immediately reached for comment.
(Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Savio D'Souza)